Highlights
1 patentProfile claimed by owner
About
Blood Test for Early Cancer Detection
Savicell Diagnostics develops the Well-Shield platform, a blood test designed for the early detection of disease, with a focus on cancer. The Well-Shield technology is designed to detect and interpret differential metabolic responses that can indicate disease intrusion and cell malformation, including cancer.
The company aspires to improve adherence to routine medical screenings through the use of patient-friendly blood tests. Savicell Diagnostics is a majority-owned subsidiary of Savicell Corporation, a Nevada-based corporation.
Identity
| Name | Savicell Diagnostics |
|---|---|
| Slug | savicell-diagnostics |
| Type / kind | startup |
| Crunchbase ID | savicell-diagnostics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL7K9-cKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Matam, Haifa, Israel |
Web & social
| Website | https://www.savicell.com |
|---|---|
| Careers page | http://www.savicell.com/careers.html |
| https://www.linkedin.com/company/12622819 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
diagnosticsmedical-technologiesblood-testbiotechnologycancerearly-detectionclinical-dataoncologyclinicshospitalsacademialaboratorieshealthcare-providersminimally-invasivepulmonary
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}